Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive centronuclear myopathy (AR-CNM) is an inherited neuromuscular disorder defined by numerous centrally placed nuclei on muscle biopsy and clinical features of a congenital myopathy.
Biomarker and diagnostic research for autosomal recessive centronuclear myopathy has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for autosomal recessive centronuclear myopathy.
10 publications have been identified in PubMed for autosomal recessive centronuclear myopathy. Research spans Gene Therapy / Novel Therapeutics (40%), Basic Science / Preclinical (30%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
New treatment approaches | 4 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
3 |
30% |
Testing and diagnosis research | 1 | 10% |
Patient case studies | 1 | 10% |
Disease patterns and progression | 1 | 10% |
Villar-Quiles RN (2026). [PMID: 41621159](https://pubmed.ncbi.nlm.nih.gov/41621159/). *Neuromuscular disorders : NMD*. [Gene Therapy / Novel Therapeutics]
Lin Y (2025). [PMID: 40336196](https://pubmed.ncbi.nlm.nih.gov/40336196/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Gene Therapy / Novel Therapeutics]
Zídková J (2025). [PMID: 40525497](https://pubmed.ncbi.nlm.nih.gov/40525497/). *Clinical genetics*. [Case Report / Case Series]
Akyürek EE (2025). [PMID: 41206505](https://pubmed.ncbi.nlm.nih.gov/41206505/). *Human molecular genetics*. [Gene Therapy / Novel Therapeutics]
Wang Y (2025). [PMID: 40583855](https://pubmed.ncbi.nlm.nih.gov/40583855/). *Muscle & nerve*. [Basic Science / Preclinical]
Hama Y (2025). [PMID: 40302423](https://pubmed.ncbi.nlm.nih.gov/40302423/). *Neuropathology : official journal of the Japanese Society of Neuropathology*. [Epidemiology / Natural History]
Østergård Jensen S (2024). [PMID: 39728936](https://pubmed.ncbi.nlm.nih.gov/39728936/). *Veterinary sciences*. [Diagnostic / Biomarker]
Li Q (2024). [PMID: 38725372](https://pubmed.ncbi.nlm.nih.gov/38725372/). *Journal of cachexia, sarcopenia and muscle*. [Basic Science / Preclinical]
Yavaş C (2024). [PMID: 38363456](https://pubmed.ncbi.nlm.nih.gov/38363456/). *Genes & genomics*. [Gene Therapy / Novel Therapeutics]
Bhattacharyya S (2024). [PMID: 38717859](https://pubmed.ncbi.nlm.nih.gov/38717859/). *Proceedings of the National Academy of Sciences of the United States of America*. [Basic Science / Preclinical]